1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk of disease progression in low-risk MDS is linked to distinct epigenetic subtypes - To the editor
    Research Letter

    Qin, T.; Sotzen, J.; Rampal, R. K.; Rapaport, F. T.; Levine, R. L.; Klimek, V.; Nimer, S. D.; Figueroa, M. E.
    Leukemia (2019)

    Fulltext@MSK | Save
  • Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
    Journal Article

    Pollyea, D. A.; Tallman, M. S.; de Botton, S.; Kantarjian, H. M.; Collins, R.; Stein, A. S.; Frattini, M. G.; Xu, Q.; Tosolini, A.; See, W. L.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): An alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study
    Journal Article

    Ustun, C.; Le-Rademacher, J.; Wang, H. L.; Othus, M.; Sun, Z.; Major, B.; Zhang, M. J.; Storrick, E.; Lafky, J. M.; Chow, S.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • The role of PI3K inhibition in lymphoid malignancies
    Review

    von Keudell, G.; Moskowitz, A. J.
    Current Hematologic Malignancy Reports (2019)

    Fulltext@MSK | Save
  • Clinical utilization of chimeric antigen receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - An expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
    Editorial

    Kansagra, A. J.; Frey, N. V.; Bar, M.; Laetsch, T. W.; Carpenter, P. A.; Savani, B. N.; Heslop, H. E.; Bollard, C. M.; Komanduri, K. V.; Gastineau, D. A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation in the treatment of adult acute lymphoblastic leukemia: Updated 2019 evidence-based review from The American Society for Transplantation and Cellular Therapy
    Guidelines

    DeFilipp, Z.; Advani, A. S.; Bachanova, V.; Cassaday, R. D.; Deangelo, D. J.; Kebriaei, P.; Rowe, J. M.; Seftel, M. D.; Stock, W.; Tallman, M. S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplant for HIV patients with hematologic malignancies: The BMT CTN-0903/AMC-080 trial
    Journal Article

    Ambinder, R. F.; Wu, J.; Logan, B.; Durand, C. M.; Shields, R.; Popat, U. R.; Little, R. F.; McMahon, D. K.; Cyktor, J.; Mellors, J. W.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab followed by alemtuzumab for relapsed or refractory chronic lymphocytic leukemia: A phase 2 trial of the ECOG-ACRIN Cancer Research Group (E2903)
    Journal Article

    Kempin, S.; Sun, Z.; Kay, N. E.; Paietta, E. M.; Mazza, J. J.; Ketterling, R. P.; Frankfurt, O.; Claxton, D. F.; Saltzman, J. N.; Srkalovic, G.; more...
    Acta Haematologica (2019)

    Fulltext@MSK | Save
  • Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
    Journal Article

    Rustad, E. H.; Misund, K.; Bernard, E.; Coward, E.; Yellapantula, V. D.; Hultcrantz, M.; Ho, C.; Kazandjian, D.; Korde, N.; Mailankody, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
    Journal Article

    Kurzrock, R.; Gurski, L. A.; Carlson, R. W.; Ettinger, D. S.; Horwitz, S. M.; Kumar, S. K.; Million, L.; von Mehren, M.; Benson, A. B. 3rd
    Annals of Oncology (2019)

    Fulltext@MSK | Save